TC |
Stat |
Stk |
Ins |
Fil |
+d |
+w |
+m |
+q |
+h |
+y |
avg |
|---|
Filing Date |
T Date |
Ticker |
Issuer | Inc | Sector |
Ind | Industry |
Owner |
oSt |
Rel |
Title |
T |
TVal |
Price |
L |
Qty |
oc |
Own |
H |
r2y |
r1y |
r6m |
r3m |
r6w |
r3w |
r7d |
r3d |
f1d |
f1w |
f1m |
f3m |
f6m |
f1y |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
9/5/24 16:13 | 9/3/24 | ZLAB | Zai Lab Ltd | E9 | Health | Drug | Pharmaceutical Preparations | Gaynor Richard | MA | D | S | -49 | 19.50 | 0 | -3 | -5 | 47 | D | |||||||||||||||
7/1/24 16:55 | 6/29/24 | ALKS | Alkermes Plc. | Health | Drug | Pharmaceutical Preparations | Gaynor Richard | D | M.d | 0 | 0.00 | 0 | 6 | 32 | 25 | D | |||||||||||||||||
7/10/23 20:30 | 7/7/23 | ALKS | Alkermes Plc. | Health | Drug | Pharmaceutical Preparations | Gaynor Richard | D | M.d | 0 | 0.00 | 0 | 6 | 41 | 20 | D | |||||||||||||||||
6/16/22 16:57 | 6/14/22 | ALKS | Alkermes Plc. | Health | Drug | Pharmaceutical Preparations | Gaynor Richard | D | M.d | 0 | 0.00 | 0 | 8 | 92 | 16 | D | |||||||||||||||||
12/3/21 21:24 | 12/2/21 | ALKS | Alkermes Plc. | Health | Drug | Pharmaceutical Preparations | Gaynor Richard | D | M.d | 0 | 0.00 | 0 | 6 | 166 | 9 | D | |||||||||||||||||
5/21/21 16:35 | 5/20/21 | ALKS | Alkermes Plc. | Health | Drug | Pharmaceutical Preparations | Gaynor Richard | D | M.d | 0 | 0.00 | 0 | 6 | 5 | D | ||||||||||||||||||
11/27/19 17:01 | 11/25/19 | NTGN | Neon Therapeutics, Inc. | DE | Health | BioPrd | Biological Products, (No Diag | Gaynor Richard | MA | O | P of R,D | S.m | -85 | 1.31 | 0 | -65 | -29 | 157 | D |
| D | Derivative transaction in filing (usually option exercise) |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| A | Amended filing |
| E | Error detected in filing |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |